drugset / Trial / NCT00835198

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

NCT00835198

Phase 4 Completed 163 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used with tretinoin gel 0.025% compared with tretinoin gel 0.025% monotherapy in treating moderate to severe facial acne vulgaris

Timeline

Start
2008-12
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapsone Small molecule 5 % Topical
Comparator Tretinoin Small molecule 0.025 % Topical

Indications